Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc.

Assertio Therapeutics, Inc.

Overview
Date Founded

2018

Headquarters

7999 Gateway Boulevard,Suite 300,Newark, CA 94560

Type of Company

Public

Employees (Worldwide)

116

Industries

Pharmaceuticals
IT Consulting & Services
Medical Support Services

Company Description

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Contact Data
Trying to get in touch with decision makers at Assertio Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Senior Vice President & Chief Financial Officer

Senior Vice President/General Counsel

Senior Vice President & Chief Commercial Officer

Senior Vice President Operations & Business Relationships

Senior Vice President, Chief Scientific & Technical Officer

Senior Vice President, Sales & Managed Markets & Trade

Senior Vice President, Human Resources & Administration

Senior Vice President, Investor Relations & Corporate Communications

Vice President, Sales

Board of Directors

Chief Executive Officer at Fullbeauty Brands Operations LLC

President & Chief Executive Officer at Assertio Therapeutics, Inc.

Founder at Knowledgeable Decisions LLC

Chief Executive Officer at MBJC Associates LLC

Co-Founder at Tyree & D'Angelo Partners LLC

Former President & Chief Executive Officer at Corium International, Inc.

Professional at Melinta Therapeutics, Inc.

Former Executive Vice President-Global Commercial Operations at Abbott Diabetes Care, Inc.

Paths to Assertio Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Assertio Therapeutics, Inc.
Owners & Shareholders
Details Hidden

Armistice Capital LLC is a hedge fund manager located in New York City.

Details Hidden

Senvest Management employs a contrarian, value-based investment strategy. The firm uses a variety of methods and strategies to make investment decisions and recommendations. The methods of analysis include fundamental research, charting analysis, cyclical analysis as well as use of quantitative tools and investment approaches, or technical analytical tools and approaches. Senvest Management may employ the use options, short sales, margin and leverage to implement their trading strategies.

Details Hidden

Deltec Asset Management specializes in implementing actively managed long-only investment strategies designed to generate positive absolute returns. The firm's strategies are based on the fundamental research of individual securities. Emphasis is placed on the securities of issuers that operate in out-of-favor sectors and/or securities that are poorly understood or underfollowed. Implementation of Deltec's recommendations typically does not involve frequent trading or the use of margin debt, short-sales, or derivatives. Investments include domestic and emerging market equity, debt and equivalent securities. Certain accounts also invest in non-traditional equity and debt securities, including but not limited to, contingent value rights/obligations, interests in liquidating trusts, equity equivalents with due bills entitling the holder to future distributions, defaulted corporate and sovereign debt, interests in fully funded syndicated bank loans, and trade claims.

Recent Transactions
Details Hidden

Assertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Details Hidden

Assertio Therapeutics, Inc. purchases DepoMed Development Ltd from Elan Corp. Plc

Details Hidden

Assertio Therapeutics, Inc. issued Common Stock

Insider Transactions
Details Hidden
Transaction Advisors
Accountant

Advised onBiovail Corp. purchases Assertio Therapeutics, Inc.

Legal Advisor

Advised onAssertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Underwriter

Advised onAssertio Therapeutics, Inc. issued Common Stock

Legal Advisor

Advised onAssertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Associate

Advised onAssertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Legal Advisor

Advised onAssertio Therapeutics, Inc. purchases Janssen Pharmaceuticals, Inc. /Nucynta Franchise from Johnson & Johnson

Advisors & Consultants
Legal Advisor

Partner at Hogan & Lovells LLP

Legal Advisor

Co-Chair, Securities Regulation & Corporate Governance Practice Group at Gibson, Dunn & Crutcher LLP

Legal Advisor

Partner at Gibson, Dunn & Crutcher LLP

Clients

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Collegium Pharmaceutical, Inc. operates as a pharmaceutical company, which engages in the developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR. The Xtampza ER provides pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. The Nucynta ER for the treatment of chronic pain and neuropathic pain associated with diabetic peripheral neuropathy. The Nucynta is a release formulation of tapentadol indicated for the management of acute pain severe enough to require an opioid analgesic. The company was founded by Michael Thomas Heffernan in October 2003 and is headquartered in Stoughton, MA.

Cardinal Health, Inc. engages in the provision of pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The company was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.

Key Stats and Financials As of 2018
Market Capitalization
$303M
Total Enterprise Value
$687M
Earnings Per Share
$0.57
Revenue
$312M
Net Profit
$36.9M
EBITDA
$170M
EBITDAMargin
54.58%
Total Debt
$566M
Total Equity
$220M
Enterprise Value Sales
2.2x
Enterprise Value EBITDAOperating
4.04x
TEVNet Income
18.61x
Debt TEV
0.82x
Three Year Compounded Annual Growth Rate Of Revenue
-3.11%
Five Year Compounded Annual Growth Rate Of Revenue
18.36%
Non-Profit Donations & Grants Received
Investors
Details Hidden

Morgan Stanley provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following business segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan on September 16, 1935 and is headquartered in New York, NY.

Details Hidden

Deerfield Management Co. focuses on investments in growth stocks across the healthcare sector. They target companies with sound fundamentals, long-term earnings growth potential and the potential to capitalize on market trends. Deerfield's approach is based on extensive fundamental research into healthcare sector assets and investment opportunities. They invest mainly in US companies or companies that issue securities available in US public markets. Although this is their focus, there is no geographic limitation on investments and Deerfield may invest outside the US when situations warrant. Their funds generally pursue one of 3 strategies: Large-Cap, Special Situations and Private Design.Deerfield's Large-Cap strategy invests mainly in debt and equity securities, including exchange traded derivative securities, of publicly-traded companies in the healthcare sector. The strategy seeks capital appreciation through a combination of security selection based on fundamental analysis, diversification through investments in stock, debt and derivatives and a mix of long and short positions.The firm's Special Situations strategy emphasizes investments in publicly traded healthcare companies with smaller market-caps. At least 90% of investments must in healthcare companies, and essentially all investments are healthcare related. Investments include equity, debt, royalties or other assets, some of which may have limited liquidity. The strategy makes both long and short investments and may utilize leverage.Deerfield's Private Design strategy invests in public and private healthcare companies using privately created instruments, structures and transactions. This may include, but is not limited to, joint ventures, project financing, contracting for revenue streams, purchasing products/services outright (including intellectual property), participating in LBOs, restructurings and outright buyouts, and developing/participating in the development and sale of therapeutics, medical devices and healthcare products/services.

Suppliers
Dow Chemical Company Other Business & Consulting Services | Midland, Michigan

The Dow Chemical Co. manufactures and distributes chemicals, plastics, industrial and agricultural products. It serves agriculture, automotive, building and construction, consumer, electronic materials, infrastructure, packaging, product finder and product safety industries. The company was founded by Herbert Henry Dow in 1897 and is headquartered in Midland, MI.

PDL BioPharma, Inc. Medical Support Services | Incline Village, NV

PDL BioPharma, Inc. produces and markets biopharmaceutical products. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and elsewhere. The Pharmaceutical segment covers revenues from branded prescription medicine products being sold under the name Tekturna and Tekturna HCT in the United States, and Rasilez and Rasilez HCT for the rest of the world. The Medical Devices segment handles revenues from the LENSAR Laser System sales. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.

Mipharm SpA Holding Companies | Milan, MI

Mipharm SpA manufactures specialty pharmaceuticals and generic drugs. It operates as a third party manufacturing site for various pharmaceutical brands as well as offers integrated services such as packagaing, research, and development. The company was founded by Giuseppe G. Miglio in January 1998 and is headquartered in Milan, Italy.

Competitors
Pfizer, Inc. Pharmaceuticals - New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Teva Pharmaceutical Industries Ltd. Pharmaceuticals - Petach Tikva, HM

Teva is a global generic pharmaceuticals leader and one of the top 15 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide. Established in 1901, Teva takes great pride in its long tradition of leadership and dedication to excellence

Arbor Pharmaceuticals LLC Pharmaceuticals - Atlanta, GA

Arbor Pharmaceuticals LLC develops pharmaceutical products which focus on cardiovascular, hospital and pediatric markets. It offers edarbyclor, cetylev, horizant, zenzedi, evekeo, sklice, and eryhromycin. The company was founded by Jarrett T. Disbrow and Edward J. Schutter and is headquartered in Atlanta, GA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Assertio Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Assertio Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Assertio Therapeutics, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/depomed-inc-29878
  • https://relationshipscience.com/organization/depomed-inc-29878